← causal

Neurodegen (broad)

0 causal edges 7 causal effects 12 hypotheses 0 open gaps 8 papers

Causal-edge map (sample)

Explore in Knowledge Graph →
mechanism:APOE4 removalmechanism:TFEB overexpremechanism:epigenetic silmechanism:vesicular tranprocess:Glucose Metabolimechanism:energy metabolmechanism:microglial senmechanism:proteostasis f

Inner ring = highest depth_score (out-edges − in-edges). Outer ring = next-most-upstream. Edge thickness = claimed confidence.

Top causal effects

Quantitative effect-size rows from substrate_causal_effects (Q-CAUSAL Phase 1). Sorted by |effect_size| desc.

  1. mechanism epigenetic silencing → disease neurodegeneration — p n/a LLM_inferred
  2. process Glucose Metabolic Reprogramming → disease Neurodegeneration — p n/a LLM_inferred
  3. mechanism proteostasis failure → disease neurodegeneration — p n/a LLM_inferred
  4. mechanism microglial senescence → disease neurodegeneration vulnerability — p n/a LLM_inferred
  5. mechanism energy metabolism disorders → disease Parkinson's disease-like neurodegeneration — p n/a LLM_inferred
  6. mechanism vesicular transport disruption → disease neurodegeneration vulnerability — p n/a LLM_inferred
  7. mechanism APOE4 removal → mechanism tau-mediated neurodegeneration protection — p n/a LLM_inferred

Upstream-target candidates

Ranked by depth_score = out-edges − in-edges. High score = strong upstream signal.

  1. mechanism:APOE4 removal +1 0 mentions
  2. mechanism:TFEB overexpression +1 0 mentions
  3. mechanism:epigenetic silencing +1 0 mentions
  4. mechanism:vesicular transport disruption +1 0 mentions
  5. process:Glucose Metabolic Reprogramming +1 0 mentions
  6. mechanism:energy metabolism disorders 0 0 mentions
  7. mechanism:microglial senescence 0 0 mentions
  8. mechanism:proteostasis failure 0 0 mentions

Leading hypotheses

  1. Astrocyte GAT-3 dysfunction and inhibitory-network disruption in ALS/FTD
  2. TREM2-dependent microglial lipid handling in Alzheimer's disease
  3. ER-mitochondria contact-site dysfunction in neurodegeneration
  4. TDP-43 phase-separation and nuclear-function failure in ALS/FTD
  5. USP13 Stabilization of PINK1/Parkin Mitophagy in Parkinson's Disease
  6. PINK1/Parkin-pathway mitophagy impairment in sporadic Parkinson's disease
  7. Glial Metabolic Coupling Failure in Neuronal Bioenergetic Crisis
  8. Lysosomal GBA1 Enhancement via Glucosylceramide Reduction
  9. Complement C1q/C3 Blockade for Alzheimer's Disease
  10. circRNA dysregulation as neurodegeneration biomarker and exploratory therapeutic biology
  11. Glial Progenitor Cell Support in Huntington's Disease
  12. OPC exhaustion and failed remyelination in progressive multiple sclerosis